Annual General Meeting of Agfa-Gevaert NV - regulated information

13.05.25 17:40 Uhr

Werte in diesem Artikel

                                       

May 13, 2025 – 5.40 PM CET
Regulated information

Wer­bung

Annual General Meeting of Agfa-Gevaert NV

Mortsel, Belgium – May 13, 2025 – 5.40 p.m. CET

At Agfa-Gevaert's Annual General Meeting, the 2024 financial statements, the allocation of the result, the remuneration report, the remuneration policy and the discharge of directors and statutory auditor were approved.

Furthermore, the shareholders rendered available all share premiums that can be rendered available without specific formalities, in order to allow the Board of Directors to use these share premiums to offset losses incurred.

Wer­bung

PwC Bedrijfsrevisoren BV/PwC Réviseurs d’Entreprises SRL was appointed as statutory auditor charged with the assurance of the stand-alone and consolidated sustainability information of the Company. The shareholders also approved the fees for the assurance of this information.

About Agfa-Gevaert
The Agfa-Gevaert Group is a leading company in imaging technology and IT solutions with over 150 years of experience. The Group holds three divisions: Radiology Solutions, HealthCare IT and Digital Print & Chemicals. They develop, manufacture and market analogue and digital systems for the healthcare sector, for specific industrial applications and for the printing industry. In 2024, the Group realized a turnover of 1,138 million euro.

Contact:
Viviane Dictus
Director Corporate Communications
tel. +32 0 3 444 7124
e-mail: viviane.dictus@agfa.com

Wer­bung

Attachment


Ausgewählte Hebelprodukte auf Agfa-Gevaert

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Agfa-Gevaert

NameHebelKOEmittent
NameHebelKOEmittent
Wer­bung

Nachrichten zu Agfa-Gevaert N.V.

Wer­bung

Analysen zu Agfa-Gevaert N.V.

DatumRatingAnalyst
14.11.2012Agfa-Gevaert holdING
08.11.2012Agfa-Gevaert outperformExane-BNP Paribas SA
07.08.2012Agfa-Gevaert outperformExane-BNP Paribas SA
09.05.2012Agfa-Gevaert holdING
21.03.2012Agfa-Gevaert neutralUBS AG
DatumRatingAnalyst
08.11.2012Agfa-Gevaert outperformExane-BNP Paribas SA
07.08.2012Agfa-Gevaert outperformExane-BNP Paribas SA
24.05.2010Agfa-Gevaert "buy"ING
18.05.2010Agfa-Gevaert "buy"ING
18.02.2008Agfa-Gevaert kaufenDie Actien-Börse
DatumRatingAnalyst
14.11.2012Agfa-Gevaert holdING
09.05.2012Agfa-Gevaert holdING
21.03.2012Agfa-Gevaert neutralUBS AG
14.03.2012Agfa-Gevaert holdING
05.01.2012Agfa-Gevaert holdING
DatumRatingAnalyst
07.01.2008Agfa-Gevaert DowngradeUBS AG

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Agfa-Gevaert N.V. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen